Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of
the American College of Cardiology/American Heart Association Task Force on Clinical …

Background To help adapt cardiovascular disease risk prediction approaches to low-income
and middle-income countries, WHO has convened an effort to develop, evaluate, and …

Aims The aim of this study was to develop, validate, and illustrate an updated prediction
model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk …

Cardiovascular disease (CVD) is the leading cause of death worldwide and a major public
health concern. CVD prediction is one of the most effective measures for CVD control. In this …

[CQ1] What is the role of 99 mTc-PYP scintigraphy (bone scintigraphy) in clinical practice for
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …

Abstract Objective Electronic health records (EHRs) are a rich source of information on
human diseases, but the information is variably structured, fragmented, curated using …

The SPARTE study (Strategy for Preventing cardiovascular and renal events based on
ARTErial stiffness; URL: https://www. clinicaltrials. gov; Unique identifier: NCT02617238) is a …

Objective To compare the impact of ezetimibe and proprotein convertase subtilisin/kexin
type 9 (PCSK9) inhibitors on cardiovascular outcomes in adults taking maximally tolerated …

Yvonne Commodore-Mensah, PhD, RN, FAHA, FPCNA† Paul A. Heidenreich, MD, MS,
FACC, FAHA Dhaval Kolte, MD, PhD Paul Muntner, PhD, FAHA Sidney C. Smith Jr, MD …